Trial Profile
To compare the treatment outcomes of Alemtuzumab vs Natalizumab, Fingolimod and Interferon β in patients with Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Nov 2016
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary) ; Fingolimod; Interferon beta; Natalizumab
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 20 Nov 2016 New trial record